Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - Other
Ratios

Seres Therapeutics (MCRB) Leases (2019 - 2025)

Seres Therapeutics (MCRB) has disclosed Leases for 7 consecutive years, with $72.5 million as the latest value for Q4 2025.

  • Quarterly Leases fell 10.41% to $72.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $72.5 million through Dec 2025, down 10.41% year-over-year, with the annual reading at $72.5 million for FY2025, 10.41% down from the prior year.
  • Leases hit $72.5 million in Q4 2025 for Seres Therapeutics, down from $74.7 million in the prior quarter.
  • In the past five years, Leases ranged from a high of $111.0 million in Q4 2022 to a low of $8.4 million in Q1 2021.
  • Historically, Leases has averaged $66.5 million across 5 years, with a median of $77.8 million in 2025.
  • Biggest five-year swings in Leases: surged 509.53% in 2022 and later dropped 25.65% in 2025.
  • Year by year, Leases stood at $18.2 million in 2021, then soared by 509.53% to $111.0 million in 2022, then decreased by 18.53% to $90.4 million in 2023, then dropped by 10.52% to $80.9 million in 2024, then dropped by 10.41% to $72.5 million in 2025.
  • Business Quant data shows Leases for MCRB at $72.5 million in Q4 2025, $74.7 million in Q3 2025, and $76.8 million in Q2 2025.